Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 37 of the 38 references it cites were found in a registry or an index.

A supportive care intervention for people with metastatic melanoma being treated with immunotherapy: a pilot study assessing feasibility, perceived benefit, and acceptability

Abstract

Introduction: Increasing numbers of metastatic melanoma (MM) patients are receiving immunotherapy treatment, including pembrolizumab, and the impact on their well-being is underexplored. Objectives: To assess the feasibility of a multimodal supportive care program to MM patients being treated with pembrolizumab. Methods: This pre-post-test feasibility cohort study recruited MM participants treated with pembrolizumab: (i) supportive care intervention with usual care and (ii) usual care. The intervention comprised comprehensive medical assessment by supportive care physician (SCP), exercise physiologist (EP), and dietitian then a tailored supportive care program. Programs included exercise, dietary advice, non-invasive complementary therapies, and psychology consultation. Outcome measures included adherence, patient-reported symptoms, anxiety and depression, and toxicity. Descriptive data are reported. Results: We recruited 28 participants: 13 intervention and 15 control; three did not complete the study. Most were male, with median age 66 (range 42–85) years. All intervention participants completed baseline assessments with SCP, EP, and dietitian. Two missed follow-up with EP or dietitian. Symptoms most troubling at baseline were as follows: fatigue (n = 6), sleep (n = 6), general aches and pains (n = 5), and memory (n = 4). All intervention participants were prescribed 16 exercise sessions; 8 (50%) completed all; overall exercise adherence was 85%. Integrative therapies were accessed by 85% (11) participants. Immunotherapy-related adverse event rates were low and SCP consultation identified symptoms not captured by CTCAE 4.0. Conclusions: A holistic supportive care intervention tailored to individual needs is feasible. The symptom burden in MM patients was low. Further investigation of the intervention is warranted, focused on populations with higher symptom burden to improve outcomes. © 2018, Springer-Verlag GmbH Germany, part of Springer Nature.

Overview

Integrity signals

Registry

Crossref · 10.1007/s00520-018-4524-3

Cites

37 of 37 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Citations

Cites

Show all 38 references

Research works printed but not linked: 1

  1. Office QoL (2018) Calculating nom-based T-scores from your FACT-G data. POCOG, University of Sydney, Sydney Available from: www.pocog.org.au/pod/factgscores.aspx

Cited by

See all 42

Metadata

Authors
Lacey, J., Lomax, A. J., McNeil, C., Marthick, M., Levy, D., Kao, S., Nielsen, T., & Dhillon, H. M.
Affiliations
  • The University of Sydney (AU)
  • Chris O’Brien Lifehouse (AU)
Corresponding author
Lacey, Judith
Venue
Supportive Care in Cancer
Published
2018-11-03
Volume
27
Issue
4
Pages
1497-1507
ISSN
  • 0941-4355 (ISSN-L)
  • 1433-7339
OpenAlex
W2898934815
Cited by
42
References
38
Citations by year
2025: 9 · 2024: 4 · 2023: 10 · 2022: 8 · 2021: 4 · 2020: 5 · 2019: 1 · 2018: 1
FWCI
1.03
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • Supportive Care in Cancer (publishedVersion)
  • PubMed (publishedVersion)
Funders
MSD Ltd (N/A)
Topics
  • Health Sciences › Medicine › Oncology › Cancer survivorship and care
  • Health Sciences › Medicine › Oncology › Cutaneous Melanoma Detection and Management
  • Health Sciences › Medicine › Complementary and alternative medicine › Complementary and Alternative Medicine Studies
Keywords
metastatic melanoma, pembrolizumab, immunotherapy, supportive care, exercise intervention, dietary recommendations, integrative therapy, symptom burden, fatigue, anxiety and depression, immunotherapy toxicity, feasibility, patient-reported outcomes, holistic care
MeSH terms
Adult, Aged, Aged, 80 and over, Combined Modality Therapy, Diet Therapy, Exercise Therapy, Feasibility Studies, Female, Humans, Immunotherapy, Male, Melanoma, Middle Aged, Neoplasm Metastasis, Palliative Care, Patient Acceptance of Health Care, Perception, Pilot Projects, Quality of Life, Cohort Studies, Risk Assessment, Musculoskeletal Manipulations, Antibodies, Monoclonal, Humanized

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A supportive care intervention for people with metastatic melanoma being treated with immunotherapy: a pilot study assessing feasibility, perceived benefit, and acceptability. https://app.cochat.ai/papers/10.1007/s00520-018-4524-3
The paper
Lacey, J., Lomax, A. J., McNeil, C., Marthick, M., Levy, D., Kao, S., Nielsen, T., & Dhillon, H. M. (2019). A supportive care intervention for people with metastatic melanoma being treated with immunotherapy: a pilot study assessing feasibility, perceived benefit, and acceptability. Supportive Care in Cancer. https://doi.org/10.1007/s00520-018-4524-3

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.